Although NADPH oxidase can favor endothelial dysfunction through different mechanisms, the quenching and inactivation of endothelial NO by an excess production of reactive oxygen species is a major mechanism linking NADPH oxidase activation and impaired vasodilation [12], [13]. The gene discussed is FMO5; the disease is endothelial dysfunction.